跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
DAIVOBET 50 MICROGRAMOS/0,5 MG/G POMADA
Approved
STANDARD
DAIVOBET 50 MICROGRAMOS/0,5 MG/G POMADA
Leo Pharma A/S
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 5, 2026
Approval ID
bca59f8e2744a274
Company
Leo Pharma A/S
Type
Standard
Approval Details
Approval Id
bca59f8e2744a274
Drug Cima Aemps Name
DAIVOBET 50 MICROGRAMOS/0,5 MG/G POMADA
Register Number
BE239303
Holder Company Name
Leo Pharma A/S
Marketing Company Name
Melyfarma S.L.
Holder Company Detail Path
/organization/leo-pharma-a-s
Authorization Date
2026-06-05
Dosage Form
POMADA
Dose
0,5 mg/50 mcg
Route Of Administration
USO CUTÁNEO
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Leo Pharma A/S
Company Detail Path
/organization/leo-pharma-a-s
Company Information
Pharmaceutical Company Name
LEO Pharma A/S
Name En
LEO Pharma A/S
Country Name
Denmark
City Name
Ballerup
Address
Ballerup, Copenhagen, Denmark
Website
https://www.leo-pharma.com
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 5, 2026
Approval ID
bca59f8e2744a274
Type
Standard
Back to CIMA-AEMPS Approvals
DAIVOBET 50 MICROGRAMOS/0,5 MG/G POMADA - CIMA-AEMPS Drug Approval Details